160 related articles for article (PubMed ID: 36379683)
21. Analysis of CHOP rearrangement in pleomorphic liposarcomas using fluorescence in situ hybridization.
Sugita S; Seki K; Yokozawa K; Tochigi N; Furuta K; Hisaoka M; Hashimoto H; Shimoda T; Hasegawa T
Cancer Sci; 2009 Jan; 100(1):82-7. PubMed ID: 19037998
[TBL] [Abstract][Full Text] [Related]
22. DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.
Bento C; Andersson MK; Aman P
BMC Cell Biol; 2009 Dec; 10():89. PubMed ID: 20017906
[TBL] [Abstract][Full Text] [Related]
23. A Patient with Myxoid/Round Cell Liposarcoma (MRCL) Involving the Well-known Translocation t(12;22): A Case Report with the Cytogenomic Landscape of this Rearrangement.
Tirado CA; Su W; Chia V; Zaki M; Tang R; Eastwood K; Guardiola MT; Rao A
J Assoc Genet Technol; 2022; 48(2):68-75. PubMed ID: 35660675
[TBL] [Abstract][Full Text] [Related]
24. Vulvar Myxoid Liposarcoma and Well Differentiated Liposarcoma With Molecular Cytogenetic Confirmation: Case Reports With Review of Malignant Lipomatous Tumors of the Vulva.
Schoolmeester JK; Leifer AJ; Wang L; Hameed MR
Int J Gynecol Pathol; 2015 Jul; 34(4):390-5. PubMed ID: 25851712
[TBL] [Abstract][Full Text] [Related]
25. Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses.
Svec D; Dolatabadi S; Thomsen C; Cordes N; Shannon M; Fitzpatrick P; Landberg G; Åman P; Ståhlberg A
Lab Invest; 2018 Jul; 98(7):957-967. PubMed ID: 29588491
[TBL] [Abstract][Full Text] [Related]
26. [Detection of chromosomal translocation in fresh samples of myxoid/round cell liposarcoma by long-distance polymerase chain reaction].
Xiang H; Wang J; Hisaoka M; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):412-3. PubMed ID: 17822629
[No Abstract] [Full Text] [Related]
27. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
[TBL] [Abstract][Full Text] [Related]
28. Myxoid liposarcoma with pleomorphic cells: Report of two cases with molecular confirmation of FUS gene rearrangements.
Uchihashi K; Matsuyama A; Nakayama M; Sakamoto A; Shiba E; Hisaoka M
Pathol Res Pract; 2016 Nov; 212(11):1067-1070. PubMed ID: 27515548
[TBL] [Abstract][Full Text] [Related]
29. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
[TBL] [Abstract][Full Text] [Related]
30. Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.
Göransson M; Elias E; Ståhlberg A; Olofsson A; Andersson C; Aman P
Int J Cancer; 2005 Jul; 115(4):556-60. PubMed ID: 15688424
[TBL] [Abstract][Full Text] [Related]
31. Expression of CTAG1B clone EPR13780 versus
Abdelaziz MM; Tayel HY; Abdel-Bary A; Badawy OM
J Histotechnol; 2022 Jun; 45(2):56-65. PubMed ID: 34845972
[TBL] [Abstract][Full Text] [Related]
32. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification.
Murshed KA; Abo Samra H; Ammar A
Head Neck Pathol; 2022 Mar; 16(1):288-293. PubMed ID: 34089125
[TBL] [Abstract][Full Text] [Related]
33. FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma.
Trautmann M; Menzel J; Bertling C; Cyra M; Isfort I; Steinestel K; Elges S; Grünewald I; Altvater B; Rossig C; Fröhling S; Hafner S; Simmet T; Åman P; Wardelmann E; Huss S; Hartmann W
Clin Cancer Res; 2017 Oct; 23(20):6227-6238. PubMed ID: 28637688
[No Abstract] [Full Text] [Related]
34. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.
de Graaff MA; Yu JS; Beird HC; Ingram DR; Nguyen T; Juehui Liu J; Bolshakov S; Szuhai K; Åman P; Torres KE; Lev D; Nielsen TO; Bovée JV; Lazar AJ; Somaiah N
Lab Invest; 2016 Aug; 96(8):885-94. PubMed ID: 27270875
[TBL] [Abstract][Full Text] [Related]
35. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
36. Myxoid liposarcoma with cartilaginous differentiation: A case study with fish analysis and review of the literature.
Ioannou MG; Kouvaras E; Papamichali R; Karachalios T; Koukoulis G
Pathol Res Pract; 2013 Oct; 209(10):666-9. PubMed ID: 23920321
[TBL] [Abstract][Full Text] [Related]
37. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma.
Sandberg AA
Cancer Genet Cytogenet; 2004 Nov; 155(1):1-24. PubMed ID: 15527898
[No Abstract] [Full Text] [Related]
38. A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.
Hosaka T; Nakashima Y; Kusuzaki K; Murata H; Nakayama T; Nakamata T; Aoyama T; Okamoto T; Nishijo K; Araki N; Tsuboyama T; Nakamura T; Toguchida J
J Mol Diagn; 2002 Aug; 4(3):164-71. PubMed ID: 12169678
[TBL] [Abstract][Full Text] [Related]
39. A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression.
Oikawa K; Tanaka M; Itoh S; Takanashi M; Ozaki T; Muragaki Y; Kuroda M
Br J Cancer; 2012 Jun; 106(12):1976-9. PubMed ID: 22588557
[TBL] [Abstract][Full Text] [Related]
40. Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas.
Huang HY; Antonescu CR
Ultrastruct Pathol; 2003; 27(4):217-26. PubMed ID: 12907366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]